Financial results - G.M.P. GLOBAL MACHINERY FOR PHARMACEUTICALS SRL

0.00
Financial Summary - G.m.p. Global Machinery For Pharmaceuticals Srl
Unique identification code: 15116136
Registration number: J23/260/2017
Nace: 4614
Sales - Ron
73.930
Net Profit - Ron
30.225
Employee
1
Open Account
The most important financial indicators for the company G.m.p. Global Machinery For Pharmaceuticals Srl - Unique Identification Number 15116136: sales in 2023 was 73.930 euro, registering a net profit of 30.225 euro and having an average number of 1 employees. Firma isi desfasoara activitatea in domeniul Intermedieri in comertul cu masini, echipamente industriale, nave si avioane having the NACE code 4614.

Sales, Profit, Employees, Debts, Capitals, Financial Results - G.m.p. Global Machinery For Pharmaceuticals Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 167.036 274.566 43.286 119.607 79.142 82.117 83.168 113.660 120.484 73.930
Total Income - EUR 168.692 276.660 43.462 120.415 79.298 82.451 83.399 113.731 120.876 80.571
Total Expenses - EUR 43.018 39.453 42.550 41.350 47.155 42.862 36.206 52.143 48.238 43.767
Gross Profit/Loss - EUR 125.673 237.207 913 79.065 32.143 39.589 47.193 61.587 72.638 36.803
Net Profit/Loss - EUR 105.252 198.350 -3 65.712 31.352 38.768 46.409 60.473 71.457 30.225
Employees 1 1 1 1 1 1 1 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales decreased by -38.5%, from 120.484 euro in the year 2022, to 73.930 euro in 2023. The Net Profit decreased by -41.015 euro, from 71.457 euro in 2022, to 30.225 in the last year.
See Company Data

Check the financial reports for the company - G.m.p. Global Machinery For Pharmaceuticals Srl

Rating financiar

Rating financiar -
G.m.p. Global Machinery For Pharmaceuticals Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - G.m.p. Global Machinery For Pharmaceuticals Srl - CUI 15116136

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 720 361 595 1.131 1.945 2.286 3.154 234 338 488
Current Assets 105.709 200.256 27.397 64.468 30.516 39.055 47.726 62.165 88.296 32.218
Inventories 0 0 0 0 0 0 0 6.353 6.372 6.353
Receivables 7.677 9.509 13.173 20.279 21.033 20.082 18.417 7.313 75.705 11.628
Cash 98.032 190.747 14.224 44.189 9.483 18.973 29.309 48.500 6.219 14.237
Shareholders Funds 105.787 198.890 531 66.235 31.867 39.274 46.905 60.959 71.943 30.710
Social Capital 446 450 445 438 430 421 413 404 406 404
Debts 410 1.705 27.100 1.388 934 1.726 1.952 1.801 16.714 2.228
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "4614 - 4614"
CAEN Financial Year 7022
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 32.218 euro in 2023 which includes Inventories of 6.353 euro, Receivables of 11.628 euro and cash availability of 14.237 euro.
The company's Equity was valued at 30.710 euro, while total Liabilities amounted to 2.228 euro. Equity decreased by -41.015 euro, from 71.943 euro in 2022, to 30.710 in 2023.
Monitors the Company

Activate a subscription with unlimited access and get contact details for any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Recurring - monthly payment

Pay

25,21 EUR / month
NELIMITAT

Reports that can be accessed based on the subscription:

  • ✔ Financial Rating
  • ✔ Payment Limits
  • ✔ Outstanding Debts
  • ✔ Probability of Insolvency
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
See Subscriptions

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.